Health Plan Week
Today’s issue is brought to you by AIS's Health Plan Week, the industry's leading source of objective business, financial and regulatory news of the health insurance industry. Sign up for a $91 two-month trial subscription today.

December 16, 2016

Today's Featured Story

Gingrich: Republicans Will Be Cautious in ACA Replacement
Reprinted from Health Plan Week

In their quest to repeal and replace the Affordable Care Act (ACA), Republican lawmakers will be cautious in their approach, former House Speaker Newt Gingrich (R-Ga.) said during a Dec. 7 webinar sponsored by the law firm Dentons, where he is now a senior advisor.... Read Full Story


Quote of the Day

Anthem Inc.’s proposed acquisition of Cigna Corp. is “not perfect, but it gives them some independence from [the Blue Cross and Blue Shield Association] in trying to cobble together a national network for the national accounts market.”

— Ana Gupte, an equities analyst at Leerink Partners, LLP, at the Brookings Institution’s 21st annual “Wall Street Comes to Washington” roundtable, according to The AIS Report on Blue Cross and Blue Shield Plans*.

Click here to read the THE AIS REPORT ON BLUE CROSS AND BLUE SHIELD PLANS* article in which this quote appeared — " Anthem Leaders Likely Regret Pushing for a Speedy Trial With DOJ" (Free for THE AIS REPORT subscribers; $17 for non-subscribers.)

* Not affiliated with the Blue Cross and Blue Shield Association or its member companies.


Today's Datapoint

115.5 million ... people are enrolled in self-funded/ASO plans nationwide in plans administered by health insurers. UnitedHealthcare serves the largest number of self-funded/ASO enrollees, with 21.8 million covered lives, or 18.9% of the market.

From AIS’s Directory of Health Plans


Today from Washington

People on the Move

Civitas Senior Living promoted Vice President of Operations Cooper Vittitow to chief operating officer....Neogen Corporation named Dan Kephart as its chief science officer, a newly created position. Kephart has served as research and development director for the agribusiness unit of Thermo Fisher Scientific....Muse bio appointed Dr. Kevin Ness CEO and a member of the board of directors. He succeeds Muse bio's founding CEO, Ryan Gill, who becomes the company's chief science officer and remains Slade Professor, Chemical and Biological Engineering and executive director of the BioDesign Center at the RAS Energy Institute at the University of Colorado, Boulder. Prior to joining Muse bio, Ness was co-founder, chief technology officer and chief operating officer of 10X Genomics


The Featured Story of the day may be accessed on the day it is transmitted without logging in to Thereafter, you may need to log in to access the Featured Story. If you haven’t yet registered on, please take a minute to create a free account now and get free access to thousands of articles, blogs and much more.

Content questions or suggestions should be directed to Executive Editor Jill Brown at If you are interested in advertising in AIS's HEALTH BUSINESS DAILY, please contact BJ Taylor at

AIS's HEALTH BUSINESS DAILY is copyrighted and protected by federal law. The re-use of its content is restricted (see below). However, you are permitted to forward this email to as many of your friends and colleagues as you wish, or better yet have them sign up for their own copy at atlantic_subscription.cfm

Copyright © 2016 Managed Markets Insight & Technology, LLC. All rights reserved. It is not permissible to include all or any portion of this content on any Web site, intranet or electronic network or in any print publication, without AIS's written permission in advance. Permission requests should be directed to

With archives of AIS's Health Business Daily, features like the News Archives, AIS Blogs and more! (Free registration required)

AISHealth  Follow AISHealth on Twitter  Follow AISHealth on Facebook  Follow AISHealth on LinkedIn



AIS E-Savings Club Weekly Specials
Health Plan Week
AIS's Directory of Health Plans: 2016 Is Shipping Now!
The AIS Guide to Blue Cross and Blue Shield Plans
The Challenges of Pharmacy Star Ratings: Solutions for Part D Plan Sponsors and Their Partners